Clementine Secures Seed Funding
Clementine, a Maastricht-based startup, has successfully raised €1.7 million in a seed funding round led by Healthy.Capital. This investment will support the company's mission to enhance how hearing care brands prioritize, personalize, and convert leads using artificial intelligence and behavioral science.
Company Overview
Founded by Vince Van De Weijer, who serves as the CEO, Clementine focuses on providing AI-powered solutions to hearing clinics. The platform is designed to help clinics follow up with potential customers effectively, ensuring that patient inquiries are addressed promptly. "Clinics don’t need more leads; they need better conversations at the right moment," said Van De Weijer. "Our AI Hearing Care Agent ensures no patient inquiry goes unanswered."
Lead Investor: Healthy.Capital
The seed round was led by Healthy.Capital, an Amsterdam-based investor known for its focus on HealthTech startups. The firm has a track record of investing in companies like Pharmi and MS Sherpa, aiming to drive innovation in healthcare.
Strategic Use of Funds
The newly acquired funds will be used primarily to enhance Clementine's AI platform and expand its reach within the hearing healthcare industry. The company aims to improve the way hearing clinics convert leads into actual patients, thereby increasing access to hearing healthcare services.
Conclusion
With this funding, Clementine is well-positioned to advance its technological offerings and make a significant impact on the hearing care sector. The company's innovative approach could potentially change how hearing disabilities are managed and treated globally.